Compare Bio-Rad Laboratories, Inc. Class A Common Stock (BIO) vs Cincinnati Financial Corporation (CINF) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Bio-Rad Laboratories, Inc. Class A Common Stock vs Cincinnati Financial Corporation — how do they compare? Bio-Rad Laboratories, Inc. Class A Common Stock trades at $298.3 (market cap $8.04B), while Cincinnati Financial Corporation trades at $182.62 (market cap $27.85B). The key difference: Cincinnati Financial Corporation is far larger — about 3.5× Bio-Rad Laboratories, Inc. Class A Common Stock's market cap, and Cincinnati Financial Corporation pays a 2.09% dividend while Bio-Rad Laboratories, Inc. Class A Common Stock pays none. Which is the better fit depends on your goals.
| BIO | CINF | |
|---|---|---|
Market Cap | $8.04B | $27.85B |
Sector | Health | Financials |
52-Week High | $339.75 | $192.03 |
52-Week Low | $241.71 | $145.80 |
Enterprise Value | $7.85B | $27.52B |
Dividend Yield | — | 2.09% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
BIO trades at $297.58, up 0.5% on the day, with a bullish technical signal from moving averages and a consensus analyst price target of $305. The stock shows strong profitability with a 51.87% gross margin and positive net income of $760M in 2025, though recent quarters have seen EPS misses. Cash flow from operations remains robust at $532M, supporting financial stability.
Outlook is cautiously optimistic with analyst support, but risks include earnings volatility and high P/E valuation. The company's return to profitability and solid balance sheet provide a foundation for growth, though investors should monitor execution against future earnings expectations and competitive pressures in the biotech sector.
Cincinnati Financial (CINF) trades at $182.67, up 1.89% with strong technical momentum near recent highs. The stock shows solid fundamentals with a P/E of 10.44, ROE of 18.73%, and consistent earnings beats in recent quarters. Recent news highlights the company's 65-year dividend streak and upcoming Q2 2026 earnings release on July 27, 2026. Operating cash flow improved to $3.11B in 2025, supporting financial stability.
CINF presents a balanced investment case with attractive valuation metrics and strong profitability, though catastrophe losses and claims costs remain key risks. Analyst consensus suggests moderate upside to the $188.67 price target. The stock's technical positioning near resistance at $184 requires monitoring of earnings performance for continued momentum.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Bio-Rad Laboratories, Inc. Class A Common Stock
Bio-Rad Laboratories, headquartered in Hercules, California, develops, manufactures, and markets products and solutions for the clinical diagnostics and life sciences markets. In diagnostics (53% of sales), Bio-Rad manufactures, sells, and supports test systems and specialized quality controls for clinical laboratories. In life sciences (47% of sales), the firm develops and manufactures a range of instruments and reagents used in research, biopharmaceutical production, and food testing. The company is geographically diverse, with major markets in the Americas (42% of 2021 sales), Europe and Africa (33%), and Asia-Pacific (25%). Bio-Rad owns 37% of Sartorius AG, a laboratory and biopharmaceutical supplier.
Read more on BIO →About Cincinnati Financial Corporation
Cincinnati Financial Corp is a property and casualty insurance company that generates income through written premiums. A select group of independent agencies actively markets the company's business, home, and automotive insurance within their communities. These agents offer the company's personal lines as well as its standard market, excess, and surplus commercial line policies in many regions in the United States. Cincinnati Financial also offers leasing and financing services. The vast majority of the company's revenue is generated through commercial lines, followed by personal lines.
Read more on CINF →
